A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

New Computational Method Reveals Congestive Heart Failure Feb. 6, 2025 — A team of physicists has developed a groundbreaking method for detecting congestive heart failure with greater ease and ...

Congestive heart failure (CHF) and heart failure are the same thing. Both terms describe the inability of the heart to pump enough blood to service the body's needs. The term "congestive" simply ...

left ventricular ejection fraction (LVEF), peak oxygen (VO2), and six-minute walk test scores, with heart-failure-related hospitalisations also being assessed as a secondary endpoint. At last year ...

which is present in approximately 50% of heart failure cases. If LVEF is 40% or less a patient is considered to have heart failure with reduced ejection fraction (HFrEF), sometimes known as ...

Heart failure; LVEF: Left ventricular ejection fraction; MERIT-HF: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure; NA: Not available; SENIORS: Study of the Effects of ...

In the subgroup analyses stratified by Vmax and LVEF, there were no significant interactions between the subgroup factors and the effect of high LVMI for the primary outcome measure in both the ...

aCardiovascular R&D Centre – UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto 4200-319, Portugal ...

These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...